Dr. Jonathan David Herman, MD, PhD

Dr. Herman practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Herman's NPI, 1104289586, was assigned on April 1, 2016. Dr. Herman graduated from Harvard Medical School in 2014. Dr. Herman holds California license 199882.

Dr. Herman's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Herman's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Herman is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Herman to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Herman practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Herman's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Herman is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Herman's licenses on file in 3 states: California, Massachusetts and New York.

CMS data shows 59 Medicare services from Dr. Herman across 2 procedure codes in 2024, for 24 Medicare patients. Medicare paid $5,985 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 24 Medicare patients who saw Dr. Herman in 2024. 75% of them have high blood pressure, and 63% have chronic kidney disease. 50% are also on Medicaid. Their average risk score is 4.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Herman's median patient age at 58, with 44% women.

In 2022, Dr. Herman wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $551 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

Dr. Herman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Herman as offering telehealth.

Dmand AI links Dr. Herman to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases.

Dr. Herman graduated from Harvard Medical School in 2014.

Dr. Herman is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.